← Back to Search

Device

tDCS administered for Delirium

N/A
Waitlist Available
Led By Uma Suryadevara, MD
Research Sponsored by North Florida/South Georgia Veterans Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with presence of delirium, confirmed by "Confusion Assessment Method". Age > 21 years old Hospitalized at the Malcom Randall Veterans Affairs Hospital. Number of patients who will be recruited: 100
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time points at which the measurement will be done is within 5 minutes to an hour after procedure and another one will be done 4 to 5 hours later.
Awards & highlights

Study Summary

Delirium is induced by changes in cortical excitability and transcranial direct current stimulation (tDCS), by using weak electrical fields, can modulate cortical excitability and spontaneous firing activities in the stimulated region by shifting the resting membrane. One half of the subjects will receive stimulation via tDCS and the other half will receive sham tDCS for 20 minutes per day, 5 days per week, for 1 week. Symptoms will be monitored using the Confusion Assessment Method.

Eligible Conditions
  • Delirium
  • Confusion

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time points at which the measurement will be done is within 5 minutes to an hour after procedure and another one will be done 4 to 5 hours later.
This trial's timeline: 3 weeks for screening, Varies for treatment, and time points at which the measurement will be done is within 5 minutes to an hour after procedure and another one will be done 4 to 5 hours later. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction in signs and symptoms of delirium

Side effects data

From 2021 Phase 2 & 3 trial • 160 Patients • NCT02483468
2%
Car accident
2%
skin irritation
100%
80%
60%
40%
20%
0%
Study treatment Arm
tDCS (Active)
tDCS (Sham)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: tDCS administeredExperimental Treatment1 Intervention
Subjects will receive stimulation via tDCS (Transcranial Direct Current Stimulation) for 20 minutes per day, 5 days per week, for 1 week.
Group II: Sham tDCS administeredPlacebo Group1 Intervention
Subjects will receive sham tDCS (Transcranial Direct Current Stimulation) for 20 minutes per day, 5 days per week, for 1 week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Direct Current Stimulation
2014
Completed Phase 3
~1100

Find a Location

Who is running the clinical trial?

North Florida/South Georgia Veterans Health SystemLead Sponsor
7 Previous Clinical Trials
1,885 Total Patients Enrolled
Uma Suryadevara, MDPrincipal InvestigatorMalcom Randall VAMC
1 Previous Clinical Trials
14 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Transcranial Direct Current Stimulation for the Treatment of Delirium
2016. "Transcranial Direct Current Stimulation for the Treatment of Delirium". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03256500.
All > Tdcs
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top